insulin novo nordisk - Search News

FDA Declares Shortage of Novo Nordisk's Wegovy, Ozempic

Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.

Bloomberg on MSN · 1d

Novo’s Ozempic Shortage Is Declared Over, Hitting Copycats

Novo Nordisk A/S’s weight-loss and diabetes drugs are no longer in short supply, US regulators said, a decision that’s expected to curtail widespread access to cheaper copies of the popular medications.

STAT · 1d

Novo Nordisk shortage of Ozempic and Wegovy ends, threatening compounders

The FDA has declared an end to the shortage of Novo Nordisk’s blockbuster drug semaglutide, threatening the ability for compounding pharmacies to make copies of Ozempic and Wegovy.

15hon MSN

Why Novo Nordisk A/S (NVO) Surged On Friday?

We recently published a list of Five Chinese Firms Dominate Friday’s Top 10 Gainers. In this article, we are going to take a ...

3hon MSN

Lilly, Novo dominance to continue as TD Cowen lifts 2030 GLP-1 sales forecast by 38%

Eli Lilly (LLY) and Novo Nordisk (NVO) to dominate as TD Cowen lifts 2030 sales forecast for GLP-1 class of obesity/ diabetes ...

1don MSN

Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA says

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the ...

1don MSN

Novo Nordisk A/S (NVO): Is It The Most Oversold Healthcare Stock to Buy Now?

We recently published a list of the 12 Most Oversold Healthcare Stocks to Buy Now. In this article, we are going to take a ...

Novo Nordisk Prices In Too Few New Patients For GLP-1 Currently

Novo Nordisk only prices in management's latest year guidance and underestimates the full market potential. See why I rate ...

FiercePharma1d

Novo Nordisk's semaglutide shortage officially concludes in the US, spelling major threat for weight loss drug compounders

Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...

6don MSN

2 Important Insights From Novo Nordisk's Earnings Call

Novo Nordisk has been looking to diversify its lineup in recent years, and is developing medicines in other fields. The ...

13d

Novo Nordisk (NVO) Investors are Alerted of the Pending Class Action and are Urged to Contact BFA Law by March 25 Deadline

New York, New York-- (Newsfile Corp. - February 9, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Novo Nordisk (NYSE: NVO) and certain ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results